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Androgen and estrogen biosynthesis in mammals requires the 17,20-lyase activity of cytochrome
P450 17A1 (steroid 17-hydroxylase/17,20-lyase). Maximal 17,20-lyase activity in vitro requires the
presence of cytochrome b5 (b5), and rare cases of b5 deficiency in human beings causes isolated
17,20-lyase deficiency. To study the consequences of conditional b5 removal from testicular Leydig
cells in an animal model, we generated Cyb5flox/flox:Sf1-Cre (LeyKO) mice. The LeyKO male mice
had normal body weights, testis and sex organ weights, and fertility compared with littermates.
Basal serum and urine steroid profiles of LeyKO males were not significantly different than
littermates. In contrast, marked 17-hydroxyprogesterone accumulation (100-fold basal) and re-
duced testosterone synthesis (27% of littermates) were observed after human chorionic gonad-
otropin stimulation in LeyKO animals. Testis homogenates from LeyKO mice showed reduced
17,20-lyase activity and a 3-fold increased 17-hydroxylase to 17,20-lyase activity ratio, which were
restored to normal upon addition of recombinant b5. We conclude that Leydig cell b5 is required
for maximal androgen synthesis and to prevent 17-hydroxyprogesterone accumulation in the
mouse testis; however, the b5-independent 17,20-lyase activity of mouse steroid 17-hydroxylase/
17,20-lyase is sufficient for normal male genital development and fertility. LeyKOmale mice are a
good model for the biochemistry but not the physiology of isolated 17,20-lyase deficiency in
human beings. (Molecular Endocrinology 30: 469–478, 2016)
Androgen biosynthesis requires the enzyme steroid 17-hydroxylase/17,20-lyase (P450 17A1) to convert 21-
carbon steroids to 19-carbon steroids. P450 17A1 from
all species studied catalyzes 17-hydroxylation with simi-
lar rates for substrates pregnenolone and progesterone
(Prog), yielding 17-hydroxypregnenolone and 17-hy-
droxyprogesterone (17OHP), respectively. The 17,20-
lyase reaction, however, shows species-specific substrate
preferences, with human P450 17A1 catalyzing the con-
version of 17-hydroxypregnenolone to dehydroepiandro-
sterone about 50-fold more efficiently than 17OHP to
androstenedione (AD), whereas the rodent enzymes use
both pathways. The 17,20-lyase reaction is more vulner-
able than the 17-hydroxylase reaction to disruption from
the abundance of its electron transfer protein cytochrome
P450-oxidoreductase (POR) (1), to mutations in POR,
and to phospholipid composition. Because the 17,20-
lyase activity is the sole gateway to all androgens, the
potent P450 17A1 inhibitor abiraterone was developed
for the treatment of castration-resistant prostate cancer
(2, 3). The prodrug abiraterone acetate suppresses testos-
terone (T) synthesis in prostate cancer patients and nor-
malizes androgen production in adult women with un-
controlled classic 21-hydroxylase deficiency (4).
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Cytochrome b5 (b5) is a small, highly conserved 15-
kDa hemoprotein cofactor for multiple oxidative reac-
tions, including the metabolism of fats and steroids, re-
duction of methemoglobin to hemoglobin, and the
catabolism of xenobiotics and drugs (5–9). The full-
lengthmicrosomal form of b5 is found on the cytoplasmic
side of the endoplasmic reticulum in many tissues, and a
soluble form lacking the C-terminal membrane anchor is
abundant in erythrocytes (10). Multiple studies since the
1960s have confirmed the importance of b5 as a modifier
of various cytochrome P450 activities, although its mech-
anism of action remains controversial and might vary
with P450 isoforms and substrates. Several mechanisms
have been proposed, including direct transfer of electrons
to P450s from either reduced nicotinamide adenine dinu-
cleotide-b5 reductase or POR (11) vs an allosteric effect
on the P450s and/or POR (12, 13). Depending on the
substrate and enzyme, b5 can serve as an obligate com-
ponent of the reaction or as a modifier of a reaction for
the same P450. For example, P450 2B4-catalyzed metab-
olism of methoxyflurane shows an absolute requirement
for b5 (14); in contrast, b5 inhibits the metabolism of
benzphetamine by P450 2B4 (15). In the P450 4A sub-
family, which consists of eicosanoid and fatty acid hy-
droxylases, b5 can increase or decrease theMichaelis con-
stant of the reaction, depending on the substrate involved
(16).
P450 17A1 also shows substrate-specific modulation
via b5 (12). Similar to the substrate-specific modulation
of activity observed with b5 and other P450s, b5 stimu-
lates the 17, 20-lyase reaction rate more than 10-fold
when 17-hydroxypregnenolone or 17OHP are substrates,
but b5 only increases the conversion of 5-pregna-
3,17-diol-20-one to androsterone, the most efficient
17,20-lyase reaction for human P450 17A1, by 3-fold
(17, 18). Evidence from experiments with apo-b5, which
lacks the heme and thus cannot transfer electrons, sug-
gests that b5 action on P450 17A1 does not involve direct
electron transfer (12), and b5 might act as an allosteric
modulator, promoting interaction of POR with P450
17A1 and/or conformational changes that enhance
17,20-lyase activity.
Combined 17-hydroxylase/17,20-lyase deficiency is
found in rare patients, and isolated 17,20-lyase deficiency
is one of the rarest hereditary defects in steroidogenesis
(19). Genetic screening allowed the identification of mu-
tations in both P450 17A1 and POR that almost com-
pletely ablate 17,20-lyase activity yet only partially im-
pair 17-hydroxylase activity (20). Most recently, 2
reports have identified consanguineous families with iso-
lated 17,20-lyase deficiency due to mutation in the
CYB5A gene encoding b5 (21). Unlike other forms of
isolated 17,20-lyase deficiency, patients with b5 defects
demonstrate complete preservation of 17-hydroxylase ac-
tivity, confirming the in vivo importance of b5 in stimu-
lating the 17,20-lyase reaction.
The in vivo functions of b5 have recently been explored
with mouse models of b5 deletion, including a hepatic
only deletion (22) and a complete b5-null mouse (23).
Complete deletion of b5 causes profound changes in the
metabolism of various substrates, in accordance with its
role as a regulator of numerous P450 activities. Surpris-
ingly, McLaughlin et al (23) observed only a 50% reduc-
tion in intratesticular T in b5-null animals, despite a pro-
found defect in conversion of 17OHP to AD. The b5-null
mice, unlike human patients with b5 mutations, were fer-
tile and anatomically indistinguishable from wild-type
(WT) littermates (23). Nevertheless, the contribution of
altered hepatic T metabolism, which is also a b5-depen-
dent process, confounds the interpretation of these stud-
ies. To further explore the importance of b5 in the P450
17A1-catalzyed 17,20-lyase reaction, we have generated
a mouse model with deletion of b5 in testicular Leydig
cells but not the liver. Through in vivo analysis of andro-
gen synthesis and in vitro analysis of P450 17A1 activity,
we demonstrate the physiologic importance of b5 activat-
ing the 17,20-lyase reaction and the production of 19-
carbon sex steroids from 21-carbon precursors.
Materials and Methods
Generation of animals, breeding experiments, and
histology
The Cyb5flox/ mice were generously provided by Professor
C. Roland Wolf and Dr Colin J. Henderson, Cancer Research
UK, Ninewells Hospital and Medical School, Dundee, United
Kingdom via Dr Hao Zhu, University of Kansas. Cyb5flox/flox
mice were maintained by random breeding on a 129P2 *
C57BL6 genetic background, and Sf1-Cre transgenic mice were
maintained on a C57BL6 background as described (24).
Cyb5flox/flox:Sf1-Cre mice were backcrossed to Cyb5flox/flox
mice to generate conditional b5 knockout animals. The presence
of the floxed Cyb5 alleles and Sf1-Cre transgenes was deter-
mined as previously described (22, 25). Cyb5flox/flox:Sf1-Cre:
Srd5a1/ mice were generated by crossing Cyb5flox/flox:Sf1-
Crewith Srd5a1/mice.Mice were genotyped for the presence
of Srd5a1 as previously described (26). Male mice were studied
to provide interpretable data focusing on androgen synthesis
without the complications of cyclicity and high conversion to
estrogens. The Institutional Animal Care and Research Advi-
sory Committee of the University of Texas Southwestern Med-
ical Center approved all animal protocols. All mice used in ex-
periments were fed a standard irradiated chow diet and housed
in a temperature-controlled environment with a 6 AM to 6 PM
light-dark cycle. Unless specified, mice used in experiments were
6–8 weeks old.
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Fertility was assayed by placing fertile WT female mice with
individually housed male mice. Breeding cages were surveyed
daily for the presence of pups that if found were removed and
killed. Adult animals were killed by asphyxiation with isoflu-
rane and then exsanguination via cardiac puncture; pups were
killed by decapitation. For stimulation of steroidogenesis, hu-
man chorionic gonadotropin (hCG) (Sigma) was dissolved in a
0.9% saline solution for a final concentration of 100 mIU/mL.
Mice were administered 100 L of hCG solution or vehicle via
an ip injection and killed 2 hours later. Tissue fixation, hema-
toxylin and eosin staining, andmicroscopy for histological anal-
yses were conducted according to standard protocols.
RT-PCR, immunoblotting, urine and blood
collection, and dynamic testing
For RNA extraction, frozen liver or testis samples were ho-
mogenized in 500 L of RNA-STAT60 (Isotex Diagnostics),
100L of chloroformwas added, and the phaseswere separated
by centrifugation. The upper phase was removed, and RNAwas
precipitated with 500 L of ice-cold n-propanol. After centrif-
ugation, the pellet was washed with 70% ethanol, followed by
deoxyribonuclease treatment and reverse transcription using
random hexamers to generate cDNAs. Reverse transcriptase-
quantitative PCR analyses used 25 ng of cDNA and 150 nmol of
primers mixed with SYBR GreenER PCR Master Mix (Invitro-
gen). Reactions were performed on an ABI PRISM 7900 HT
(Applied Biosystems), andmRNA levels were calculated by nor-
malization to cyclophilin using the comparative cycle threshold
method.Cyb5 primers were designed using Primer Express (Ap-
plied Biosystems): 5-CGATCTGACCAAGTTTCTCGAA-3
and 5-CCCCAGCTTGCTCTCTTAGG-3.
For protein analyses, frozen livers were homogenized in pro-
tein-lysis buffer containing 10mM Tris-HCl (pH 7.5), 150mM
NaCl, 0.5%4-nonylphenyl poly(ethylene glycol), 10%glycerol,
5mM EDTA, and 1 complete miniprotease inhibitor tablet per
10 mL (11836153001; Roche). Samples were homogenized and
centrifuged at 13 000g for 20 minutes. The supernatant was
assayed for protein concentration using a colorimetric assay.
Testis homogenates used for enzyme assay (see below) were
mixed 2:1 with sample buffer (Laemmli sample buffer; Bio-Rad)
and boiled for 5 minutes. For immunoblots, 40–50 g of pro-
teinwere resolved on 4%–20%Tris-glycine SDS-PAGE gels and
transferred to polyvinylidene difluoride membranes at 7 V for 1
hour. Incubation with primary rabbit polyclonal human anti-
Cyb5 antibody (1:500; Abcam) was performed in Tris-buffered
saline containing 0.05% Tween and 3% BSA. After washing,
incubation with secondary goat antirabbit IgG horseradish per-
oxidase-conjugated antibody (1:10 000; PerkinElmer) was per-
formed in Tris-buffered saline containing 0.1% Tween and 5%
fat-free milk. Clarity Western enhanced chemiluminescent sub-
strate (Bio-Rad) was used to visualize results. HRP-conjugated
anti--actin antibody was used as a loading control (1:1000;
Cell Signaling).
Blood obtained through cardiac puncture as previously de-
scribed was collected in EDTA-coated microfuge tubes. Plasma
was separated and used for steroid profiling. Urinewas collected
from the wells of 96-well plates placed at the base of cages with
individual mice. Mice were placed in the urine-collection cages
for 2 hours a day for 5 days to minimize stress, and urine col-
lected from the same mouse on different days was pooled for
analysis.
Enzyme assay
Recombinant tetrahistidine-tagged human b5 was prepared
as described (27). Testes (80–130 mg) were homogenized in
0.25mL of 0.25M sucrose containing 10mMTris-HCl (pH 7.0)
and 1mM EDTA with 10 strokes of Teflon homogenizer. The
debris was pelleted by centrifuging 3 minutes at 5000g and
discarded, and the decanted crude homogenate was stored fro-
zen at 20°C until use. Aliquots (10 L) were incubated with
10M[3H]-labeled Prog or 17OHP (100 000 counts perminute
per incubation) and 1mM reduced nicotinamide adenine dinu-
cleotide phosphate in 50mM potassium phosphate buffer (pH
7.4) with and without 2–30 pmol b5 (estimated 5 pmol b5/pmol
P450 17A1 based on activity) at 37°C in a total volume of 0.5
mL for 30 minutes. Steroids were extracted with 1 mL 1:1 ethyl
acetate/isooctane or 1 mL dichloromethane. After centrifuga-
tion at 8000 rpm for 1minute, the organic phasewas transferred
into glass tubes and concentrated under nitrogen. Samples were
reconstituted with 20 L methanol, and 5-L samples were
injected into an Agilent 1260 Infinity HPLC system equipped
with UV detector and -RAM4 in-line scintillation counter
(LabLogic). Steroid standards and samples were resolved on a
Kinetex 50  2.1 mm, 2.6 m particle size C8 column (Phe-
nomenex) and methanol-water gradients as described (28),
mixed with Bio-SafeII scintillation cocktail (Research Products
International), and quantitated by integration of radioactivity
peaks using Laura4 software (LabLogic).
Plasma steroid profiling by liquid chromatography-
tandem mass spectrometry (LC-MS/MS)
A 50-L aliquot of plasma was deproteinated with acetoni-
trile and methanol containing deuterated internal standards,
and steroids were extracted and quantitated using an Agilent
1290 binary pump HPLC attached to an Agilent 6490 triple
quadrupole tandem mass spectrometer as described (29, 30).
Assay performance characteristics and precursor/product ion
pairs were reported in these references.
Urine steroid metabolite profiling by gas
chromatography-mass spectrometry
Steroids in a 0.5- to 1-mL sample of urine were extracted,
derivatized, and quantitated as previously described (31). In
mice, the major androgen metabolite is an incompletely charac-
terized androstanetriolone, which when fully silylated gives a
molecular ion of M  416 m/z. Excretion of metabolites in
untimed samples were normalized to volume and expressed as
area under the curve per mL urine.
Results
Generation of Leydig cell b5 knockout (LeyKO)
mice
To study the in vivo role of microsomal b5 in testicular
steroid synthesis, we generated LeyKO mice by crossing
Cyb5flox/flox and Sf1-Cre transgenic strains. Cyb5mRNA
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was reduced 40% in testis from Cyb5flox/:Sf1-Cre mice
and 80% in Cyb5flox/flox:Sf1-Cre mice (subsequently re-
ferred to as LeyKO), whereas expression in the liver was
unchanged (Figure 1A). Immunoreactive b5 proteins ap-
peared similar in homogenates of liver and testis from
LeyKO mice compared with floxed littermates, with 2
major b5 species in testis from all animals (Figure 1B).
Because Leydig cells compose only approximately 5% of
testis mass, the residual b5 expression might derive from
other cell types, which comprisemost testis tissue, or from
incomplete recombination. LeyKO mice were viable and
born at the expected Mendelian ratio. LeyKO male mice
were observed to be phenotypically normal, with no dif-
ferences in internal or external sexual development be-
tween knockout mice and floxed littermates.
LeyKO mice have normal body weight, sex organ
weight, and fertility
Testicular histology revealed no defects in testicular
development in LeyKO mice (Figure 1C). To determine
the impact on sexual maturation, wemeasured the weight
of the epididymis, vas deferens, seminal vesicles, preputial
glands and testis from LeyKO mice and compared them
with floxed littermates (Table 1). No significant differ-
ences were observed between the 2 groups. Additionally,
no differences in body weight were observed between
LeyKO and floxed littermates (Table 1). Decreased an-
drogen production would be expected to relieve feedback
inhibition on the hypothalamus and pituitary, leading to
an increase in gonadotropins; however, no increase in
FSH or LH was seen in LeyKO mice (Table 1). To deter-
mine whether LeyKOmice had any defects in their ability
to reproduce, we individually housed LeyKO and floxed
littermates with WT females and measured litter size and
frequency. No differences in litter size or frequency were
observed between the 2 cohorts (Table 1), indicating that
LeyKO mice had no defect in their ability to copulate.
These results are consistent with previously published
data on global b5-null mice that were found to be viable,
fertile, and anatomically indistinguishable fromWTmice
(23).
LeyKO mice show slight changes in basal plasma
and urine steroid profiles
Given the strong stimulatory effect of b5 on the P450
17A1-catalyzed 17,20-lyase reaction, we anticipated that
deletion of b5 from Leydig cells would decrease circulat-
ing 19-carbon steroids AD and T and lead to an accumu-
lation of 21-carbon precursors, par-
ticularly 17OHP. Using LC-MS/MS
to profile plasma steroids, we found
neither a significant decrease in AD
and T nor a significant increase in
17OHP and Prog (Table 1). Further-
more, plasma 17OHP concentra-
tions were consistently low or unde-
tectable (0.5 ng/mL) in both
LeyKO mice and floxed littermates,
and in agreement with previous
studies, plasma T did not exceed
0.5–1 ng/mL (32). These results sug-
gest that residual 17,20-lyase activ-
ity in the absence of b5 was suffi-
cient to maintain the low basal level
of T synthesis in male mice without
accumulation of precursors. An al-
ternative explanation is that b5-de-
pendent extratesticular androgen
synthesis compensates for the lack
of testicular AD and T production in
LeyKO mice; however, this hypoth-
esis is unlikely given the minor re-
ductions in plasma T found in global
b5-null animals (23). To confirm
these findings, we performed uri-
nary steroid metabolite profiling by
Figure 1. Specific deletion of b5 in testis but not liver. A, RT-qPCR analysis of Cyb5 mRNA
expression in testis and liver from mice that are Cyb5flox/flox (WT), Cyb5flox/:Sf1-Cre (Cyb5 Het),
and Cyb5flox/flox:Sf1-Cre (LeyKO). Data are mean  SD, and statistics were determined with 2-
tailed t test (***, P  .0005). B, Immunoblot analysis of b5 protein in liver and testis
homogenates from WT and LeyKO mice, using -actin as a loading control and migration of
molecular mass standards (kDa) at left. C, Hematoxylin and eosin staining of testis sections from
WT and LeyKO mice both show normal histology (magnification 20).
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gas chromatography-mass spectrometry, which was used
to demonstrate impaired 17,20-lyase activity in patients
with b5 deficiency (21). Urine samples from 10-week-old
LeyKO mice and floxed littermates (n  10 each group)
showed slightly lower amounts of the major androstan-
etriolone androgen metabolite compared with floxed lit-
termates (area under the curve per mL urine 
2 042 000  927 000 vs 2 786 000  865 000, respec-
tively; P .09). These data demonstrate minimal changes
in basal steroid production in LeyKO mice.
Stimulation of steroid production exposes
accumulation of 17OHP and Prog in LeyKO mice
Unlike human beings, exposure of male mice to a re-
ceptive female or soiled bedding from a receptive female
activates the vomeronasal reflex and stimulates LH re-
lease and T synthesis, with circulating T increasing to 6
ng/mL within 20–60 minutes of exposure (33, 34). Thus,
basal T production rates in mice are low and a poor test
for a partial blockade in 17,20-lyase activity. To simulate
a transient robust burst of androgen synthesis and P450
17A1-catalyzed steroidogenesis, LeyKO mice and floxed
littermates were injected with 10 mIU of hCG and killed
2 hours later, when plasmaT peaks after hCG stimulation
(35). Plasma T increased approximately 100-fold (to
37  12 ng/mL) after hCG stimulation in floxed animals
relative to saline controls, whereas AD rose only 5-fold
with negligible accumulation of 21-carbon precursors
17OHP or Prog (Figure 2A). In contrast, plasma T rose
only 18-fold (to 11 5 ng/mL) and AD 2-fold after hCG
stimulation in LeyKO mice; however, a marked accumu-
lation of plasma 17OHP (to 36  12 ng/mL) and lesser
accumulation of Prog was observed, relative to a slight
increase in floxed controls. Thus, hCG stimulation elic-
ited a similar augmentation of steroidogenesis in WT and
LeyKO animals, but the lack of b5 in Leydig cells of
LeyKO animals impaired 17,20-lyase activity sufficiently
to detain the flux of steroids above the partial block and
to affordmarked 17OHP accumulation. Plasma dehydro-
epiandrosterone was less than 0.02 ng/mL in all 23 basal
or hCG-stimulated samples tested from LeyKO mice and
floxed littermates (data not shown).
When analyzed as the sum of steroids before and after
the 17,20-lyase reaction, the ratio of 21-carbon precur-
sors Prog and 17OHP to the 19-carbon products AD and
T ([Prog  17OHP]/[ADT]) was not significantly dif-
ferent between unstimulated LeyKO mice and floxed lit-
termates (Figure 2B). Upon hCG stimulation of steroido-
Table 1. Characterization of LeyKO Male Mice vs Littermates
Sex organ and body weights
WT (n  9) LeyKO (n  8)
Mean (mg) SD Mean (mg) SD
Vas deferens 5.0 0.6 4.8 0.6
Epididymis 15.5 6.5 14.6 2.2
Seminal vesicle 34.6 6.7 32.9 10.5
Preputial gland 25.4 5.8 23.4 8.2
Testis 39.3 7.3 36.5 7.7
Body weight 24 600 3500 26 200 5100
Plasma FSH/LH
WT (n  5) LeyKO (n  9)
Mean (ng/mL) SD Mean (ng/mL) SD
LH 0.16 0.15 0.27 0.32
FSH 106 37 135 54
Fertility
WT (n  5) LeyKO (n  5)
Mean SD Mean SD
Days between litters 28.2 8.5 23.2 3.6
Litter size 7.3 2.0 7.4 1.2
Basal plasma steroids
WT (n  5) LeyKO (n  4)
Mean (ng/mL) SD Mean (ng/mL) SD
Progesterone 6.92 1.92 10.2 2.83
17-hydroxyprogesterone 0 0 0.45 0.90
Testosterone 0.38 0.08 0.59 0.65
Androstenedione 0.76 0.13 0.74 0.16
11-deoxycortisol 0.83 0.47 0.86 0.19
Corticosterone 65.1 18.9 63.1 25.5
11-deoxycorticosterone 1.79 0.86 1.96 0.35
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genesis, however, brisk production of the androgens AD
and T is observed, with a significant decrease in the [Prog
 17OHP] to [ADT] ratio from 6 1.4 to 0.38 0.46
in normal animals (Figure 2B). In contrast, hCG stimula-
tion of LeyKO mice did not lower the elevated [Prog 
17OHP] to [ADT] ratio relative to saline-injected con-
trols (both 	8) due to proportionate accumulation of
Prog and 17OHP along with AD and T.
Addition of b5 to testicular homogenates from
LeyKO mice restores deficient 17,20-lyase activity
To confirm that loss of b5 is the Leydig cells is respon-
sible for low 17,20-lyase activity in LeyKO animals, we
assayed 17-hydroxylase and 17,20-lyase activities in tes-
ticular homogenates and expressed the results as the hy-
droxylase to lyase ratio for each testis sample, to correct
for variations in P450 17A1 content and homogenate
quality. The hydroxylase to lyase ratio increased from 1.7
in WT mice to 4.7 in LeyKO mice (Figure 2C). Addition
of exogenous b5 to the testicular homogenates restored a
normal hydroxylase to lyase ratio to LeyKOmice homog-
enates but did not change the ratio for the WT homoge-
nates, confirming that lack of Leydig cell b5 was respon-
sible for the observed decrease in 17,20-lyase activity.
Fertility and hCG stimulation of
aged LeyKO mice
Healthy mice have no observed
decrease in plasma T with aging
(36). Given their impaired 17,20-
lyase activity, we hypothesized that
absence of b5 might lead to de-
creased plasma T and consequently
decreased fertility with increasing
age in LeyKOmice. To examine this
possibility, LeyKO mice and floxed
littermates with an average age of
596 25 days were subjected to the
same battery of testing as described
above for the younger animals. We
found no differences in fertility (lit-
ter size and frequency) (data not
shown), body weight, or lean weight
and fat content assessed bymagnetic
resonance imaging between the 2 co-
horts (Table 2). Similar to young
adults, aged LeyKO mice had hCG-
stimulated plasma T concentrations
approximately 50% that of floxed
littermates with an accumulation of
plasma 17OHP 50-fold higher than
floxed littermates (Table 2). Simi-
larly, homogenates of aged LeyKO
mouse testis had an increased hy-
droxylase to lyase ratio comparedwith floxed littermates,
which was restored to normal upon addition of exoge-
nous b5 (data not shown). Consequently, we found no
significant decline in testicular function or premature fail-
ure in aged LeyKO mice.
Activation of alternate pathway of
steroidogenesis is not responsible for normal male
phenotype of LeyKO mice
An alternate pathway to dihydrotestosterone (DHT),
originally described in the tammar wallaby, is also found
in both rodents and human steroidogenic cells (37). The
5-reductase isoform Srd5a1, known to convert T to
DHT, also uses Prog and 17OHP as substrates to form
5-reduced pregnanes, which are subsequently converted
through a series of steps, including the P450 17A1-cata-
lyzed 17,20-lyase reaction, into DHT. The 17,20-lyase
reaction with key intermediate substrate 5-pregnan-
3,17-diol-20-one, however, is minimally dependent
upon b5 (17). Embryonic activation of the alternate path-
way to DHT in LeyKOmice might compensate for low T
production, explaining the complete virilization and lack
of phenotype observed in the LeyKO mice. To test this
Figure 2. Steroidogenesis stimulation with hCG leads to accumulation of Prog and 17OHP in
LeyKO mice. The Cyb5flox/flox (WT) and LeyKO male mice 2–4 months of age (n  5–7) were
injected with 10 mIU of hCG or saline, killed 2 hours later, and exsanguinated. A, Plasma levels
of Prog, 17OHP, T, AD, 11-deoxycortisol, corticosterone, and 11-deoxycorticosterone (11-DOC)
determined by LC-MS/MS. B, Ratio of plasma concentrations of 21-carbon steroids (Prog 
17OHP) to 19-carbon steroids (AD  T) as a functional measure of in vivo 17,20-lyase activity. C,
P450 17A1 activities, expressed as hydroxylase to lyase ratio in testicular homogenates from
LeyKO and WT mice (n  13–23). Testicular homogenates were incubated with either [3H]-Prog
or [3H]-17OHP, and total products were measured by HPLC with radiochemical detection to assay
17-hydroxylase and 17,20-lyase activities, respectively (see Materials and Methods). Addition of
recombinant b5 to the testicular homogenates (b5) rescued the decreased 17,20-lyase activity
in LeyKO homogenates but did not change activities in WT homogenates. Values are mean 
SD, and statistics were determined with 2-tailed t test (*, P  .05; **, P  .005; ***, P 
.0005).
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hypothesis, LeyKO mice were crossed with Srd5a1-null
mice to generate Cyb5flox/flox:Sf1-Cre:Srd5a1/ mice
(referred to as LeyKO/Srd5a1/). The LeyKO/
Srd5a1/ mice were born in normal Mendelian ratios
and had no overt differences in internal and external sex-
ual development. Fertility experiments revealed no differ-
ences in litter frequency or size between the LeyKO/
Srd5a1/ mice and Cyb5flox/flox littermates. These
results suggest that the normal sexual development in
LeyKOmice is likely due to adequate fetal androgen pro-
duction by residual 17,20-lyase activity despite the ab-
sence of b5 and not due to activation of the alternate
pathway to DHT that bypasses the need for b5.
Discussion
Abundant biochemical and limited genetic data have
shown that the small hemo-protein b5 provides func-
tions as a cofactor in methemoglobin reduction, fatty
acid desaturation, and several cytochrome P450-cata-
lyzed reactions in the metabolism of xenobiotics and
steroid hormones (8, 10, 22, 23, 38). For the P450
17A1, b5 significantly increases the rate of the 17,20-
lyase reaction that converts 21-carbon pregnanes into
19-carbon androgens. This report describes a mouse
model of conditional b5 knockout in the testicular Ley-
dig cell (LeyKO). Although LeyKO mice were found to
be phenotypically identical to floxed littermates with
similar basal plasma steroids, acute stimulation of ste-
roidogenesis led to profound differences in plasma ste-
roids using LC-MS/MS assays, with accumulation of
21-carbon pregnanes Prog and 17OHP behind the dis-
rupted 17,20-lyase reaction and impaired androgen
synthesis. In vitro studies with testicular homogenates
confirmed that the biochemical phenotype resulted
from the loss of Leydig cell b5. This study provides the
most complete characterization of the physiologic
function of b5 in activating the 17,20-lyase activity of
P450 17A1.
One limitation to our study is the use of Sf1-Cre trans-
gene for conditional deletion of the Cyb5a gene. Sf1 is
also expressed in the adrenal cortex, gonadotropes, and
certain regions of the hypothalamus. In mice, P450 17A1
expression in the adrenal cortex is low, as evidenced by
the high plasma corticosterone in all animals (Figure 2).
Although our data hint that other 21-carbon steroids of
adrenal origin also accumulate in LeyKO animals after
hCG stimulation, the effect is small compared with the
massive rise in 17OHP. Thus, the simultaneous loss of b5
in the adrenal cortex is unlikely to confound our conclu-
sions, whereas the preservation of hepatic b5 expression
is a unique advantage of our mouse model (Figure 1).
Furthermore, the hypothalamus and pituitary are not
important sites of P450 activity or androgen biosynthe-
sis from 21-carbon steroids. The poor 17,20-lyase ac-
tivity in homogenates of testes from LeyKO animals
and its rescue upon addition of b5 is strong evidence
that loss of b5 in the Leydig cells is sufficient to explain
the consistent and marked accumulation of 21-carbon
steroid precursors after hCG stimulation in these mice.
The residual Cyb5a mRNA and b5 immunoreactive
protein in LeyKO testis (Figure 1, A and B) might derive
from the seminiferous tubules, which compose most
the testicular tissue mass. Alternatively, incomplete re-
combination might account for some of the residual
17,20-lyase activity in the LeyKO mice. Even if the
Table 2. Characterization of LeyKO Aged Male Mice vs Littermates
Body weight, fat content, lean weight, testicular weight
WT (n  5) LeyKO (n  5)
Mean (mg) SD Mean (mg) SD
Testis 77.4 17.1 84.0 10.7
Fat content 16 259 4139 20 248 2421
Lean weight 26 108 2367 28 752 3207
Body weight 45 320 6391 52 340 4224
hCG-stimulated plasma steroids
WT (n  5) LeyKO (n  5)
Mean (ng/mL) SD Mean (ng/mL) SD P value
Progesterone 7.35 2.61 25.6 14.9 .027
17-hydroxyprogesterone 0.12 0.26 6.38 4.30 .012
Testosterone 10.7 8.20 5.97 2.96 .261
Androstenedione 0.23 0.13 0.06 0.06 .023
11-deoxycortisol 0.19 0.29 4.05 2.79 .015
Corticosterone 69.2 31.1 176.2 86.5 .032
11-deoxycorticosterone 1.86 1.17 13.3 9.60 .023
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LeyKO Leydig cells contain some b5 protein, the re-
duced 17,20-lyase activity in testis homogenates and its
restoration upon addition of recombinant b5 support
our conclusions, although our data might underesti-
mate the true magnitude of the b5 effect. We studied
only male animals due to the additional complexities
introduced from the estrus cycle and dominant conver-
sion of androgens to estrogens in the ovary of female
mice. Nevertheless, subsequent experiments with fe-
male “LeyKO” animals, engineered to lack b5 in the
theca and granulosa cells, would be a logical topic of
future studies.
Previous work on b5 physiology has focused on its in
vitro modulation of various P450s or its in vivo effects
on metabolism of various xenobiotics (22). A global
b5-null mouse has been described with substantial de-
fects in hepatic and extrahepatic drug metabolism (23).
The global b5-null mice were born in normal Mende-
lian ratios and were unexpectedly found to be fertile
with no overt phenotype. Similar to observations with
the global b5-null animals, LeyKO mice had normal
fertility without gross or histological changes in the
testis, epididymis, vas deferens, seminal vesicles, or
preputial glands. Our data demonstrate that normal
androgen physiology is preserved in this strain of male
mice whether b5 is deleted from the Leydig cells alone
or simultaneous deletion from the liver as well, which is
likely to reduce T catabolism.
In contrast to these findings in mice, human patients
with CYB5A mutations and a 46XY karyotype are born
with ambiguous genitalia and are universally infertile (21,
39). The 17,20-lyase activity of microsomes isolated from
LeyKOmice is significantly reduced and comparable with
the decrease in 17,20-lyase activity noted in transfected
HEK293 cells expressing human P450 17A1 and b5 mu-
tation H44L (21), demonstrating that b5 is required for
maximal 17,20-lyase activity in the Leydig cells of both
mice and humans. The differences in sexual development
and maturation observed between LeyKO mice and hu-
man patients potentially stem from differences in the spe-
cific androgen concentrations required for fetal develop-
ment. Decades of research has revealed that human fetal
male sexual development is dependent on the production
of T and its subsequent conversion to DHT via steroid
5-reductase type 2 (40). Human amniotic T concentra-
tions, measured between 11 and 21 weeks gestation, av-
erage 0.17 ng/mL for male fetuses and 0.1 ng/mL for
female fetuses (41). Direct measurements of fetal T from
fetal vein sampling between 15 and 38 weeks of gestation
average 0.61 ng/mL for male fetuses and 0.22 ng/mL for
female fetuses (42). T concentrations below a threshold
lead to graded degrees of impaired virilization, which are
inversely correlated. Male mouse fetal testes predomi-
nately produce T plus 5-androstene-3,17-diol at day
16 and 17, when virilization of the mouse urogenital tract
is known to occur (43); however, targeted disruption of
both Srd5a1 and Srd5a2 does not impair virilization (44).
Furthermore, one-third of mice engineered to express a
phosphorylation-deficient steroidogenic acute regulatory
protein are normally virilized, despite undetectable post-
natal T synthesis (45). Thus, mouse virilization is exqui-
sitely sensitive to T and does not require DHT as in hu-
mans. Consequently, the reduced T production in LeyKO
animals is still sufficient to allow normal virilization of
male mice.
In summary, we have shown impaired in vivo and in
vitro 17,20-lyase activity in testes of LeyKO male mice,
with marked accumulation of 21-carbon steroids after
hCG stimulation. Despite a 200-fold increase in the stim-
ulated [Prog17OHP] to [ADT] (precursor to product)
ratio compared with WT littermates, the lack of b5 in
Leydig cells does not affect sexual maturation, fertility, or
basal steroid levels of male mice. In contrast to the im-
paired virilization and fertility of patients with b5 defi-
ciency, the residual 17,20-lyase activity of the LeyKO
mice is sufficient to maintain normal androgen physiol-
ogy in male animals. We conclude that LeyKO mice rep-
resent a good model for the biochemistry but not the
physiology of b5 deficiency in human beings, which is one
of the rarest disorders of steroidogenesis.
Acknowledgments
We thank Professor Cedric Shackleton, University of Birming-
ham, Birmingham, UK, for helpful discussions; Dr Mala Ma-
hendroo, University of Texas Southwestern, for assistance with
mouse breeding and for providing the Srd5a1/ mice; Yuan
Zhang for technical assistance; Dr Adina Turcu, University of
Michigan, for assistancewithmass spectrometrymeasurements;
and Mr Yujin Wu, University of Michigan, for assistance with
immunoblots.
Address all correspondence and requests for reprints to: Rich-
ard J. Auchus,MD, PhD,Division ofMetabolism, Endocrinology,
and Diabetes, Department of Internal Medicine, University of
Michigan, Room 5560A, MSRBII, 1150 West Medical Center
Drive, Ann Arbor, MI 48109. E-mail: rauchus@med.umich.edu.
This work was supported by the National Institutes of
Health Grant R01GM086596 (to R.J.A.), theMedical Research
Council United Kingdom Program Grant 0900567 (to W.A.),
the Howard Hughes Medical Institute (D.J.M.), and Robert A.
Welch Foundation Grants I-1275 (to D.J.M.) and I-1558 (to
S.A.K.). B.M.O. was supported by a Sir Henry Dale fellowship
jointly funded by the Wellcome Trust and the Royal Society
(Grant 105545/Z/14/Z). Mass spectrometry used core services
supported by Grant DK089503 from the National Institutes of
476 Sondhi et al Leydig Cell b5 Knockout Mol Endocrinol, April 2016, 30(4):469–478
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 23 August 2016. at 06:53 For personal use only. No other uses without permission. . All rights reserved.
Health to the University of Michigan under the Michigan Nu-
trition Obesity Center.
Disclosure Summary: The authors have nothing to disclose.
References
1. Geller DH, Auchus RJ, Mendonça BB, Miller WL. The genetic and
functional basis of isolated 17,20-lyase deficiency. Nat Genet.
1997;17:201–205.
2. de Bono JS, Logothetis CJ, Molina A, et al. Abiraterone and in-
creased survival in metastatic prostate cancer.N Engl J Med. 2011;
364:1995–2005.
3. Ryan CJ, Smith MR, de Bono JS, et al. Abiraterone in metastatic
prostate cancer without previous chemotherapy. N Engl J Med.
2013;368:138–148.
4. Auchus RJ, Buschur EO, Chang AY, et al. Abiraterone acetate to
lower androgens in women with classic 21-hydroxylase deficiency.
J Clin Endocrinol Metab. 2014;99:2763–2770.
5. Hultquist DE, Dean RT, Douglas RH. Homogeneous cytochrome
b5 from human erythrocytes. Biochem Biophys Res Commun.
1974;60:28–34.
6. Shimakata T, Mihara K, Sato R. Reconstitution of hepatic micro-
somal stearoyl-coenzyme A desaturase system from solubilized
components. J Biochem. 1972;72:1163–1174.
7. Katagiri M, Suhara K, Shiroo M, Fujimura Y. Role of cytochrome
b5 in the cytochrome P-450-mediated C21-steroid 17,20-lyase reac-
tion. Biochem Biophys Res Commun. 1982;108:379–384.
8. Porter TD. The roles of cytochrome b5 in cytochrome P450 reac-
tions. J Biochem Mol Toxicol. 2002;16:311–316.
9. Yamazaki H, Nakamura M, Komatsu T, et al. Roles of NADPH-
P450 reductase and apo- and holo-cytochrome b5 on xenobiotic
oxidations catalyzed by 12 recombinant human cytochrome P450s
expressed in membranes of Escherichia coli. Protein Expr Purif.
2002;24:329–337.
10. Schenkman JB, Jansson I. The many roles of cytochrome b5. Phar-
macol Ther. 2003;97:139–152.
11. Hildebrandt A, Estabrook RW. Evidence for the participation of
cytochrome b 5 in hepatic microsomal mixed-function oxidation
reactions. Arch Biochem Biophys. 1971;143:66–79.
12. Auchus RJ, Lee TC, Miller WL. Cytochrome b5 augments the
17,20-lyase activity of human P450c17 without direct electron
transfer. J Biol Chem. 1998;273:3158–3165.
13. Yamazaki H, Johnson WW, Ueng YF, Shimada T, Guengerich FP.
Lack of electron transfer from cytochrome b5 in stimulation of
catalytic activities of cytochrome P450 3A4. Characterization of a
reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 re-
ductase system and studies with apo-cytochrome b5. J Biol Chem.
1996;271:27438–27444.
14. Canova-Davis E, Chiang JY, Waskell L. Obligatory role of cyto-
chrome b5 in the microsomal metabolism of methoxyflurane.
Biochem Pharmacol. 1985;34:1907–1912.
15. Morgan ET, Coon MJ. Effects of cytochrome b5 on cytochrome
P-450-catalyzed reactions. Studies with manganese-substituted cy-
tochrome b5. Drug Metab Dispos. 1984;12:358–364.
16. Loughran PA, Roman LJ, Miller RT, Masters BS. The kinetic and
spectral characterization of the E. coli-expressed mammalian
CYP4A7: cytochrome b5 effects vary with substrate. Arch Biochem
Biophys. 2001;385:311–321.
17. Gupta MK, Guryev OL, Auchus RJ. 5-reduced C21 steroids are
substrates for human cytochrome P450c17. Arch Biochem Bio-
phys. 2003;418:151–160.
18. Miller WL, Auchus RJ, Geller DH. The regulation of 17,20 lyase
activity. Steroids. 1997;62:133–142.
19. Zachmann M, Vollmin JA, Hamilton W, Prader A. Steroid 17,20-
desmolase deficiency: a new cause of male pseudohermaphrodit-
ism. Clin Endocrinol (Oxf). 1972;1:369–385.
20. Hershkovitz E, Parvari R, Wudy SA, et al. Homozygous mutation
G539R in the gene for P450 oxidoreductase in a family previously
diagnosed as having 17,20-lyase deficiency. J Clin Endocrinol
Metab. 2008;93:3584–3588.
21. Idkowiak J, Randell T, Dhir V, et al. A missense mutation in the
human cytochrome b5 gene causes 46, XY disorder of sex develop-
ment due to true isolated 17,20 lyase deficiency. J Clin Endocrinol
Metab. 2012;97:E465–E475.
22. Finn RD, McLaughlin LA, Ronseaux S, et al. Defining the in vivo
role for cytochrome b5 in cytochrome P450 function through the
conditional hepatic deletion of microsomal cytochrome b5. J Biol
Chem. 2008;283:31385–31393.
23. McLaughlin LA, Ronseaux S, Finn RD, Henderson CJ, Roland
Wolf C. Deletion of microsomal cytochrome b5 profoundly affects
hepatic and extrahepatic drug metabolism.Mol Pharmacol. 2010;
78:269–278.
24. Bingham NC, Verma-Kurvari S, Parada LF, Parker KL. Develop-
ment of a steroidogenic factor 1/Cre transgenicmouse line.Genesis.
2006;44:419–424.
25. Dhillon H, Zigman JM, Ye C, et al. Leptin directly activates SF1
neurons in the VMH, and this action by leptin is required for nor-
mal body-weight homeostasis. Neuron. 2006;49:191–203.
26. Mahendroo MS, Cala KM, Russell DW. 5-reduced androgens
play a key role in murine parturition. Mol Endocrinol. 1996;10:
380–392.
27. Naffin-Olivos JL, Auchus RJ. Human cytochrome b5 requires res-
idues E48 and E49 to stimulate the 17,20-lyase activity of cyto-
chrome P450c17. Biochemistry. 2006;45:755–762.
28. Peng HM, Liu J, Forsberg SE, Tran HT, Anderson SM, Auchus RJ.
Catalytically relevant electrostatic interactions of cytochrome
P450c17 (CYP17A1) and cytochrome b5. J Biol Chem. 2014;89:
33838–33849.
29. Turcu AF, Rege J, Chomic R, et al. Profiles of 21-carbon steroids in
21-hydroxylase deficiency. J Clin Endocrinol Metab. 2015;100:
2283–2290.
30. Rege J, Nishimoto HK, Nishimoto K, Rodgers RJ, Auchus RJ,
Rainey WE. Bone morphogenetic protein-4 (BMP4): a paracrine
regulator of human adrenal C19 steroid synthesis. Endocrinology.
2015;156:2530–2540.
31. Shackleton CH, Hughes BA, Lavery GG, Walker EA, Stewart PM.
The corticosteroid metabolic profile of the mouse. Steroids. 2008;
73:1066–1076.
32. Amstislavskaya TG, Popova NK. Female-induced sexual arousal in
male mice and rats: behavioral and testosterone response. Horm
Behav. 2004;46:544–550.
33. Bartke A, Dalterio S. Evidence for episodic secretion of testosterone
in laboratory mice. Steroids. 1975;26:749–756.
34. Macrides F, Bartke A, Dalterio S. Strange females increase plasma
testosterone levels in male mice. Science. 1975;189:1104–1106.
35. Jean-Faucher C, Berger M, de Turckheim M, Veyssiere G, Jean C.
Testosterone and dihydrotestosterone levels in epididymis, vas de-
ferens, seminal vesicle and preputial gland of mice after hCG injec-
tion. J Steroid Biochem. 1985;23:201–205.
36. Nelson JF, Latham KR, Finch CE. Plasma testosterone levels in
C57BL/6J male mice: effects of age and disease. Acta Endocrinol
(Copenh). 1975;80:744–752.
37. Ghayee HK, Auchus RJ. Basic concepts and recent developments in
human steroid hormone biosynthesis. Rev Endocr Metab Disord.
2007;8:289–300.
38. Finn RD, McLaughlin LA, Hughes C, Song C, Henderson CJ, Ro-
landWolf C. Cytochrome b5 null mouse: a new model for studying
inherited skin disorders and the role of unsaturated fatty acids in
normal homeostasis. Transgenic Res. 2011;20:491–502.
39. Kok RC, Timmerman MA, Wolffenbuttel KP, Drop SL, de Jong
doi: 10.1210/me.2015-1282 press.endocrine.org/journal/mend 477
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 23 August 2016. at 06:53 For personal use only. No other uses without permission. . All rights reserved.
FH. Isolated 17,20-lyase deficiency due to the cytochrome b5 mu-
tation W27X. J Clin Endocrinol Metab. 2010;95:994–999.
40. Auchus RJ, Miller WL. Defects in androgen biosynthesis causing
46,XY disorders of sexual development. Semin ReprodMed. 2012;
30:417–426.
41. Auyeung B, Baron-Cohen S, Ashwin E, et al. Fetal testosterone
predicts sexually differentiated childhood behavior in girls and in
boys. Psychol Sci. 2009;20:144–148.
42. Gitau R, Adams D, Fisk NM, Glover V. Fetal plasma testosterone
correlates positively with cortisol. Arch Dis Child Fetal Neonatal
Ed. 2005;90:F166–F169.
43. Mahendroo M, Wilson JD, Richardson JA, Auchus RJ. Steroid
5-reductase 1 promotes 5-androstane-3,17-diol synthesis in
immature mouse testes by two pathways. Mol Cell Endocrinol.
2004;222:113–120.
44. Mahendroo MS, Cala KM, Hess DL, Russell DW. Unexpected vir-
ilization in male mice lacking steroid 5-reductase enzymes. Endo-
crinology. 2001;142:4652–4662.
45. Sasaki G, Zubair M, Ishii T, Mitsui T, Hasegawa T, Auchus RJ.
The contribution of serine 194 phosphorylation to steroidogenic
acute regulatory protein function.Mol Endocrinol. 2014;28:1088–
1096.
478 Sondhi et al Leydig Cell b5 Knockout Mol Endocrinol, April 2016, 30(4):469–478
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 23 August 2016. at 06:53 For personal use only. No other uses without permission. . All rights reserved.
